Chemistry:Lomedeucitinib
From HandWiki
Lomedeucitinib is an investigational new drug that is being evaluated for the treatment of psoriasis and psoriatic arthritis. It is a tyrosine kinase 2 (TYK2) inhibitor.[1]
References
- ↑ "Non-Invasive Treatments Invade the Psoriasis Pipeline.". Drugs in Context 13: 2024–5–6. 2024. doi:10.7573/dic.2024-5-6. PMID 39131603.
 |  |
